R-Gem Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
- Paid Up Capital ₹ 2.00 M
- Company Age 6 Months 1 Day
About R-Gem Life Sciences
R-Gem Life Sciences Private Limited (RLSPL) is a Private Limited Indian Non-Government Company incorporated in India on 22 August 2024 ( six months 1 days old ). Its registered office is in Hyderabad, Telangana, India.
The Company is engaged in the Paper Industry.
The Company's status is Active It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 2.00 M, as per Ministry of Corporate Affairs (MCA) records.
Chitguppa Ramakanth, Varsha Badada, Sruthi Badada, and One other member serve as directors at the Company.
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U21002TS2024PTC188694
- Company No.
188694
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
22 Aug 2024
- Date of AGM
-
- Date of Balance Sheet
-
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Who are the key members and board of directors at R-Gem Life Sciences?
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Chitguppa Ramakanth  | Director | 22-Aug-2024 | Current |
| Varsha Badada | Director | 22-Aug-2024 | Current |
| Sruthi Badada | Director | 22-Aug-2024 | Current |
| Naga Kompella | Director | 22-Aug-2024 | Current |
Financial Performance of R-Gem Life Sciences.
Enhance accessibility to R-Gem Life Sciences's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of R-Gem Life Sciences?
Unlock access to R-Gem Life Sciences's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Blue Biopharma LimitedChitguppa Ramakanth is a mutual person
- Rainbow Elephant Enterprises Llp
Varsha Badada is a mutual person
- Badada Agro Food And Wellness Private Limited
Varsha Badada and Sruthi Badada are mutual person
- B3 Work Village Private Limited
Sruthi Badada is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at R-Gem Life Sciences?
Unlock and access historical data on people associated with R-Gem Life Sciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of R-Gem Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped R-Gem Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.